Q4 2018 13F Holders as of 12/31/2018
-
Type / Class
-
Equity / Common Stock
-
Number of holders
-
9
-
Total 13F shares, excl. options
-
241K
-
Shares change
-
-71.9K
-
Total reported value, excl. options
-
$181K
-
Value change
-
-$57.3K
-
Number of buys
-
4
-
Number of sells
-
-5
-
Price
-
$0.75
Significant Holders of iBio, Inc. - Common Stock (IBIO) as of Q4 2018
12 filings reported holding IBIO - iBio, Inc. - Common Stock as of Q4 2018.
iBio, Inc. - Common Stock (IBIO) has 9 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 241K shares
.
Largest 10 shareholders include Vanguard Group Inc (113K shares), GEODE CAPITAL MANAGEMENT, LLC (34.3K shares), CITADEL ADVISORS LLC (26.6K shares), BlackRock Inc. (16.9K shares), NORTHERN TRUST CORP (14.3K shares), UBS Group AG (13.3K shares), Virtu Financial LLC (10.9K shares), HighTower Advisors, LLC (10K shares), MORGAN STANLEY (1.45K shares), and BANK OF AMERICA CORP /DE/ (0 shares).
This table shows the top 9 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.